(AMH) American Homes 4 Rent - Overview
Stock: Rental Homes, Property Management, Real Estate, Single-Family
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.53% |
| Yield on Cost 5y | 4.18% |
| Yield CAGR 5y | 31.61% |
| Payout Consistency | 97.7% |
| Payout Ratio | 138.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.2% |
| Relative Tail Risk | -2.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.52 |
| Alpha | -18.16 |
| Character TTM | |
|---|---|
| Beta | 0.442 |
| Beta Downside | 0.383 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.22% |
| CAGR/Max DD | -0.02 |
Description: AMH American Homes 4 Rent January 02, 2026
American Homes 4 Rent (NYSE: AMH) is a vertically integrated REIT that acquires, develops, renovates, leases, and manages single-family rental homes across the Southeast, Midwest, Southwest, and Mountain West. As of September 30 2025 the company owned more than 61,000 properties and has earned recognitions such as a 2025 Great Place to Work, a 2025 Top U.S. Homebuilder (Builder100), and a 2025 Most Trustworthy Company (Newsweek/Statista). The firm is internally managed out of Maryland and trades under the GICS sub-industry “Single-Family Residential REITs.”
Key operating metrics that analysts watch include an occupancy rate that has hovered around 96% in 2024-25, average rent growth of roughly 5% year-over-year, and adjusted funds-from-operations (AFFO) of about $1.25 per share in the most recent quarter. The sector is being driven by a persistent shortage of new home construction, demographic shifts favoring renting among millennials and Gen Z, and the sensitivity of REIT valuations to interest-rate movements-higher rates can compress cap rates and pressure share prices, while a tight rental supply supports rent-price momentum.
If you want a data-rich, side-by-side comparison of AMH’s valuation and risk profile, the ValueRay platform offers a concise dashboard that can help you dig deeper.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 446.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.58 > 1.0 |
| NWC/Revenue: -19.91% < 20% (prev -7.10%; Δ -12.81% < -1%) |
| CFO/TA 0.06 > 3% & CFO 820.7m > Net Income 446.2m |
| Net Debt (4.82b) to EBITDA (755.0m): 6.38 < 3 |
| Current Ratio: 0.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (371.1m) vs 12m ago 0.95% < -2% |
| Gross Margin: 55.74% > 18% (prev 0.55%; Δ 5518 % > 0.5%) |
| Asset Turnover: 14.20% > 50% (prev 13.24%; Δ 0.96% > 0%) |
| Interest Coverage Ratio: 2.05 > 6 (EBITDA TTM 755.0m / Interest Expense TTM 186.3m) |
Altman Z'' -0.16
| A: -0.03 (Total Current Assets 232.5m - Total Current Liabilities 601.5m) / Total Assets 13.25b |
| B: -0.03 (Retained Earnings -400.4m / Total Assets 13.25b) |
| C: 0.03 (EBIT TTM 381.4m / Avg Total Assets 13.05b) |
| D: -0.07 (Book Value of Equity -389.8m / Total Liabilities 5.42b) |
| Altman-Z'' Score: -0.16 = B |
Beneish M -2.96
| DSRI: 1.03 (Receivables 56.8m/50.4m, Revenue 1.85b/1.70b) |
| GMI: 0.99 (GM 55.74% / 55.30%) |
| AQI: 1.01 (AQ_t 0.98 / AQ_t-1 0.97) |
| SGI: 1.09 (Revenue 1.85b / 1.70b) |
| TATA: -0.03 (NI 446.2m - CFO 820.7m) / TA 13.25b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of AMH shares?
Over the past week, the price has changed by +0.88%, over one month by +0.16%, over three months by -0.50% and over the past year by -8.94%.
Is AMH a buy, sell or hold?
- StrongBuy: 6
- Buy: 7
- Hold: 10
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AMH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.6 | 17.8% |
| Analysts Target Price | 36.6 | 17.8% |
| ValueRay Target Price | 32.2 | 3.6% |
AMH Fundamental Data Overview February 03, 2026
P/E Forward = 33.4448
P/S = 7.2234
P/B = 1.6023
P/EG = 29.82
Revenue TTM = 1.85b USD
EBIT TTM = 381.4m USD
EBITDA TTM = 755.0m USD
Long Term Debt = 4.73b USD (from longTermDebt, last quarter)
Short Term Debt = 110.0m USD (from shortTermDebt, last quarter)
Debt = 4.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.82b USD (from netDebt column, last quarter)
Enterprise Value = 18.05b USD (13.23b + Debt 4.86b - CCE 45.6m)
Interest Coverage Ratio = 2.05 (Ebit TTM 381.4m / Interest Expense TTM 186.3m)
EV/FCF = 27.27x (Enterprise Value 18.05b / FCF TTM 661.9m)
FCF Yield = 3.67% (FCF TTM 661.9m / Enterprise Value 18.05b)
FCF Margin = 35.72% (FCF TTM 661.9m / Revenue TTM 1.85b)
Net Margin = 24.08% (Net Income TTM 446.2m / Revenue TTM 1.85b)
Gross Margin = 55.74% ((Revenue TTM 1.85b - Cost of Revenue TTM 820.1m) / Revenue TTM)
Gross Margin QoQ = 55.07% (prev 55.07%)
Tobins Q-Ratio = 1.36 (Enterprise Value 18.05b / Total Assets 13.25b)
Interest Expense / Debt = 0.99% (Interest Expense 48.2m / Debt 4.86b)
Taxrate = 14.88% (69.7m / 468.1m)
NOPAT = 324.6m (EBIT 381.4m * (1 - 14.88%))
Current Ratio = 0.39 (Total Current Assets 232.5m / Total Current Liabilities 601.5m)
Debt / Equity = 0.68 (Debt 4.86b / totalStockholderEquity, last quarter 7.16b)
Debt / EBITDA = 6.38 (Net Debt 4.82b / EBITDA 755.0m)
Debt / FCF = 7.27 (Net Debt 4.82b / FCF TTM 661.9m)
Total Stockholder Equity = 7.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.42% (Net Income 446.2m / Total Assets 13.25b)
RoE = 6.23% (Net Income TTM 446.2m / Total Stockholder Equity 7.16b)
RoCE = 3.21% (EBIT 381.4m / Capital Employed (Equity 7.16b + L.T.Debt 4.73b))
RoIC = 2.67% (NOPAT 324.6m / Invested Capital 12.14b)
WACC = 5.74% (E(13.23b)/V(18.09b) * Re(7.54%) + D(4.86b)/V(18.09b) * Rd(0.99%) * (1-Tc(0.15)))
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.05%
[DCF Debug] Terminal Value 87.20% ; FCFF base≈683.4m ; Y1≈749.5m ; Y5≈954.7m
Fair Price DCF = 63.10 (EV 28.19b - Net Debt 4.82b = Equity 23.38b / Shares 370.5m; r=5.90% [WACC]; 5y FCF grow 11.09% → 2.90% )
EPS Correlation: 10.26 | EPS CAGR: -41.36% | SUE: -4.0 | # QB: 0
Revenue Correlation: 97.44 | Revenue CAGR: 9.70% | SUE: 0.24 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.21 | Chg30d=-0.007 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.80 | Chg30d=-0.063 | Revisions Net=-1 | Growth EPS=+12.6% | Growth Revenue=+5.1%